SCHEMBL4897647

SCHEMBL4897647

CCN(c1nc2cc(C(F)(F)F)ccc2s1)S(=O)(=O)c1ccc(C)c(C(=O)O)c1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 1/20 0.41
DYRK1A Q13627 1/20 0.41
AKR1B1 P15121 4/20 0.40
HDAC8 Q9BY41 2/20 0.39
HDAC3 O15379 1/20 0.39
HDAC11 Q96DB2 1/20 0.39
HDAC6 Q9UBN7 1/20 0.39
KMT2A Q03164 2/20 0.39
TP53 P04637 1/20 0.39
MAPT P10636 1/20 0.39
MEN1 O00255 1/20 0.39
ALDH1A1 P00352 1/20 0.39
HPGD P15428 1/20 0.39
ALOX15 P16050 1/20 0.39
HSD17B10 Q99714 1/20 0.39
ALOX5 P09917 1/20 0.38
POLB P06746 1/20 0.38
TRPM8 Q7Z2W7 2/20 0.38
TRPV1 Q8NER1 1/20 0.38
NCS1 P62166 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4905942 0.90 DYRK1A (0.41) DYRK1AAKR1B1HDAC8HDAC3HDAC11
SCHEMBL4906504 0.84 LMNA (0.48) LMNAKMT2ATP53MAPTMEN1
SCHEMBL4905594 0.77 TRPM8 (0.42) LMNAHDAC8HDAC3HDAC11HDAC6
SCHEMBL4904215 0.76 MEN1 (0.61) LMNAHDAC8HDAC3HDAC11HDAC6
SCHEMBL4903714 0.76 LMNA (0.56) LMNAHDAC8HDAC3HDAC11HDAC6
SCHEMBL4895709 0.76 TP53 (0.43) LMNAHDAC8HDAC3HDAC11HDAC6
SCHEMBL4897642 0.75 TRPV1 (0.50) LMNADYRK1AAKR1B1ALDH1A1ALOX5
SCHEMBL4904134 0.75 LMNA (0.54) LMNAHDAC8HDAC3HDAC11HDAC6
SCHEMBL4902640 0.74 MEN1 (0.46) LMNAKMT2AMAPTMEN1ALDH1A1
SCHEMBL4906508 0.74 LMNA (0.41) LMNAHDAC8HDAC3HDAC11HDAC6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080090829-A1 SUBSTITUTED HETEROARYL- AND PHENYLSULFAMOYL COMPOUNDS PFIZER INC. 2008-04-17 US disclosed
US-20050288340-A1 Substituted heteroaryl- and phenylsulfamoyl compounds PFIZER INC 2005-12-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050288340-A1 Substituted heteroaryl- and phenylsulfamoyl compounds PPARA, PPARG, PPARD LMNA 319/4885DYRK1A 3237/4885AKR1B1 1224/4885
US-20080090829-A1 SUBSTITUTED HETEROARYL- AND PHENYLSULFAMOYL COMPOUNDS PPARA, PPARG, PPARD LMNA 319/4885DYRK1A 3237/4885AKR1B1 1224/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.